Tae Seop Lim

894 total citations
32 papers, 682 citations indexed

About

Tae Seop Lim is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Tae Seop Lim has authored 32 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Tae Seop Lim's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Hepatitis B Virus Studies (9 papers). Tae Seop Lim is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Hepatitis B Virus Studies (9 papers). Tae Seop Lim collaborates with scholars based in South Korea, United States and Singapore. Tae Seop Lim's co-authors include A. K. Kulkarni, Kirk H. Schulz, Seung Up Kim, Do Young Kim, Katrin Schulz, Jun Yong Park, Beom Kyung Kim, Sang Hoon Ahn, Kwang‐Hyub Han and Hye Won Lee and has published in prestigious journals such as PLoS ONE, Hepatology and Thin Solid Films.

In The Last Decade

Tae Seop Lim

29 papers receiving 661 citations

Peers

Tae Seop Lim
Ja Young Kim South Korea
Seung Hwan South Korea
Myung Sub Kim South Korea
Hye Kyung Chang South Korea
Nuri Lee South Korea
Tae Seop Lim
Citations per year, relative to Tae Seop Lim Tae Seop Lim (= 1×) peers Kun‐Hua Tu

Countries citing papers authored by Tae Seop Lim

Since Specialization
Citations

This map shows the geographic impact of Tae Seop Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tae Seop Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tae Seop Lim more than expected).

Fields of papers citing papers by Tae Seop Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tae Seop Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tae Seop Lim. The network helps show where Tae Seop Lim may publish in the future.

Co-authorship network of co-authors of Tae Seop Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Tae Seop Lim. A scholar is included among the top collaborators of Tae Seop Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tae Seop Lim. Tae Seop Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Tae Seop, et al.. (2025). Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank. Journal of Cachexia Sarcopenia and Muscle. 16(2). e13757–e13757. 2 indexed citations
2.
Lim, Tae Seop, Yunfeng Cui, Tsuyoshi Todo, et al.. (2025). Outcomes of Highly Sensitized Pancreas Transplant Recipients in the Modern Era. American Journal of Transplantation. 25(8). S198–S199.
3.
Lim, Tae Seop, Yunfu Cui, Tomoki Todo, et al.. (2025). Favorable Outcomes of Pancreas Transplants from Drug Overdose Donors Supports Their Increased Utilization. American Journal of Transplantation. 25(8). S1010–S1011.
4.
Lim, Tae Seop, Seok Jong Chung, Jimin Jeon, Ja Kyung Kim, & Jinkwon Kim. (2025). The Influence of Metabolic Dysfunction-Associated Steatotic Liver Disease and Body Mass Index on the Incidence of Alzheimer Disease: A Nationwide Cohort Study. Gut and Liver. 20(1). 107–116.
5.
Lim, Tae Seop, Soon Sun Kim, Ja Kyung Kim, et al.. (2023). Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes. Gut and Liver. 17(4). 610–619. 7 indexed citations
6.
Lee, Jae Seung, Hyun Woong Lee, Tae Seop Lim, et al.. (2022). External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study. Cancers. 14(3). 711–711. 4 indexed citations
7.
Lee, Hokyou, Tae Seop Lim, Seung Up Kim, & Hyeon Chang Kim. (2022). Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population. Hepatology International. 16(6). 1308–1317. 29 indexed citations
9.
Lim, Tae Seop, Hyun Woong Lee, Ja Kyung Kim, et al.. (2021). Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B. Journal of Viral Hepatitis. 28(10). 1362–1372. 5 indexed citations
10.
Jeon, Mi Young, Tae Seop Lim, Dai Hoon Han, et al.. (2019). Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection. PLoS ONE. 14(4). e0214613–e0214613. 7 indexed citations
11.
Lee, Jae Seung, In Rae Cho, Hye Won Lee, et al.. (2019). Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database. Cancer Research and Treatment. 51(4). 1347–1356. 10 indexed citations
12.
Lim, Tae Seop, Hyungjin Rhee, Gyoung Min Kim, et al.. (2019). Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 30(8). 1194–1200.e1. 17 indexed citations
13.
Yoo, Changhoon, Joong‐Won Park, Yoon Jun Kim, et al.. (2018). Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma. Investigational New Drugs. 37(3). 567–572. 38 indexed citations
14.
Lim, Tae Seop, Do Young Kim, Kwang‐Hyub Han, et al.. (2015). Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients. Scandinavian Journal of Gastroenterology. 51(3). 344–353. 69 indexed citations
15.
Lim, Tae Seop, Beom Kyung Kim, Jong‐Sook Lee, et al.. (2014). Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker. PLoS ONE. 9(1). e86884–e86884. 25 indexed citations
16.
Lee, Kyung‐Yul, Ji Hae Nahm, Tae Seop Lim, et al.. (2013). Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum. Japanese Journal of Clinical Oncology. 43(10). 996–1003. 21 indexed citations
17.
Lim, Tae Seop, In‐Soo Kim, Young Jin Kim, et al.. (2013). Non-O1, Non-O139Vibrio choleraeSepticemia after Acupuncture. The Ewha Medical Journal. 36(Suppl). S22–S22. 5 indexed citations
18.
Roelfsema, P. R., J. P. Baluteau, E. Peeters, et al.. (1999). ISO spectroscopy of dense regions. UCL Discovery (University College London). 427. 631. 1 indexed citations
19.
20.
Kulkarni, A. K., et al.. (1997). Electrical, optical and structural characteristics of indium-tin-oxide thin films deposited on glass and polymer substrates. Thin Solid Films. 308-309. 1–7. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026